Literature DB >> 26162294

Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.

Kei Amemiya1, Jennifer L Dankmeyer2, David P Fetterer2, Patricia L Worsham2, Susan L Welkos2, Christopher K Cote2.   

Abstract

Burkholderia pseudomallei is the etiologic agent of melioidosis, which is endemic in Southeast Asia and Northern Australia. We previously found by the intraperitoneal (IP) route that we could discern differences in virulence in mice amongst different strains of B. pseudomallei. We report an early immune response study comparing two strains in our collection which represent the least, B. pseudomallei 1106a, and one of the most, HBPUB10134a, virulent strains in BALB/c mice. B. pseudomallei HBPUB10134a infected mouse spleens contained a 2-3 log higher bacterial burden than mice infected with B. pseudomallei 1106a 3 days post-infection (PI). More and higher amounts of inflammatory cytokines/chemokines were detected in sera and spleen extracts from B. pseudomallei HBPUB10134a than B. pseudomallei 1106a infected mice. The most prominent were IFNγ, IL-1α, IL-1β, IL-6, IL-10, IP-10, and MIG. After 7 days PI, there was a decrease in bacterial burden in spleens from 1106a infected mice and a decrease in cytokines/chemokines in sera and spleen extracts from both sets of mice. By day 14 PI we saw an increase in monocytes/macrophages, NK cells, and granulocytes in spleens from both sets of mice. No B. pseudomallei HBPUB10134a infected mice survived after this time. In summary, B. pseudomallei HBPUB10134a was more virulent and induced host innate immune responses typical of a more acute-type infection than did B. pseudomallei 1106a which produced a more chronic infection in mice. Published by Elsevier Ltd.

Entities:  

Keywords:  Acute infection; Burkholderia pseudomallei; Chronic infection; Immune response; Melioidosis

Mesh:

Substances:

Year:  2015        PMID: 26162294     DOI: 10.1016/j.micpath.2015.07.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848.

Authors:  David DeShazer; Sean Lovett; Joshua Richardson; Galina Koroleva; Kathleen Kuehl; Kei Amemiya; Mei Sun; Patricia Worsham; Susan Welkos
Journal:  J Med Microbiol       Date:  2019-01-10       Impact factor: 2.472

2.  Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

Authors:  Mohan Natesan; Enoka Corea; Shivankari Krishnananthasivam; Harindra Darshana Sathkumara; Jennifer L Dankmeyer; Beverly K Dyas; Kei Amemiya; Aruna Dharshan De Silva; Robert G Ulrich
Journal:  J Clin Microbiol       Date:  2017-02-08       Impact factor: 5.948

Review 3.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

4.  Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.

Authors:  R C Bernhards; C K Cote; K Amemiya; D M Waag; C P Klimko; P L Worsham; S L Welkos
Journal:  Arch Microbiol       Date:  2016-10-13       Impact factor: 2.552

5.  Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.

Authors:  Jeremy J Bearss; Melissa Hunter; Jennifer L Dankmeyer; Kristen A Fritts; Christopher P Klimko; Chris H Weaver; Jennifer L Shoe; Avery V Quirk; Ronald G Toothman; Wendy M Webster; David P Fetterer; Joel A Bozue; Patricia L Worsham; Susan L Welkos; Kei Amemiya; Christopher K Cote
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

6.  Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei.

Authors:  Sylvia R Trevino; Christopher P Klimko; Matthew C Reed; Michael J Aponte-Cuadrado; Melissa Hunter; Jennifer L Shoe; Joshua R Meyer; Jennifer L Dankmeyer; Sergei S Biryukov; Avery V Quirk; Kristen A Fritts; Steven J Kern; David P Fetterer; Lara J Kohler; Ronald G Toothman; Joel A Bozue; Christopher W Schellhase; Norman Kreiselmeier; Sharon P Daye; Susan L Welkos; Carl Soffler; Patricia L Worsham; David M Waag; Kei Amemiya; Christopher K Cote
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

7.  An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency.

Authors:  Kamal U Saikh; Jennifer L Dankmeyer; Xiankun Zeng; Robert G Ulrich; Kei Amemiya
Journal:  Immun Inflamm Dis       Date:  2018-12-19

8.  An in situ high-throughput screen identifies inhibitors of intracellular Burkholderia pseudomallei with therapeutic efficacy.

Authors:  Philip L Bulterys; Isabelle J Toesca; Michael H Norris; Jeffrey P Maloy; Sorel T Fitz-Gibbon; Bryan France; Babak Toffig; Marco Morselli; Nawarat Somprasong; Matteo Pellegrini; Herbert P Schweizer; Apichai Tuanyok; Robert Damoiseaux; Christopher T French; Jeff F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-22       Impact factor: 11.205

9.  Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei.

Authors:  Kei Amemiya; Jennifer L Dankmeyer; Jeremy J Bearss; Xiankun Zeng; Spencer W Stonier; Carl Soffler; Christopher K Cote; Susan L Welkos; David P Fetterer; Taylor B Chance; Sylvia R Trevino; Patricia L Worsham; David M Waag
Journal:  BMC Immunol       Date:  2020-02-03       Impact factor: 3.615

10.  Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.

Authors:  Sylvia R Trevino; Jennifer L Dankmeyer; David P Fetterer; Christopher P Klimko; Jo Lynne W Raymond; Alicia M Moreau; Carl Soffler; David M Waag; Patricia L Worsham; Kei Amemiya; Sara I Ruiz; Christopher K Cote; Teresa Krakauer
Journal:  PLoS Negl Trop Dis       Date:  2021-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.